Fulranumab

Fulranumab is a human IgG2 monoclonal antibody against nerve growth factor (NGF) and can be used for the research of pain[1].

Product Specifications

CAS Number

[902141-80-4]

UNSPSC

12352203

Target

Trk Receptor

Type

Inhibitory Antibodies

Related Pathways

Neuronal Signaling; Protein Tyrosine Kinase/RTK

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/fulranumab.html

Purity

96.74

Solubility

10 mM in DMSO

Smiles

[Fulranumab]

Molecular Weight

(145.37 kDa)

References & Citations

[1]Dai S, et al. Development of a method that eliminates false-positive results due to nerve growth factor interference in the assessment of fulranumab immunogenicity. AAPS J. 2014 May;16 (3) :464-77.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 3

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

MBS1466070-01 0.05 mg (E-Coli)

Recombinant Thermoanaerobacter tengcongensis Putative membrane protein insertion efficiency factor (TTE2800)

View Details

MBS1466070-02 0.2 mg (E-Coli)

Recombinant Thermoanaerobacter tengcongensis Putative membrane protein insertion efficiency factor (TTE2800)

View Details

MBS1466070-03 0.05 mg (Yeast)

Recombinant Thermoanaerobacter tengcongensis Putative membrane protein insertion efficiency factor (TTE2800)

View Details

MBS1466070-04 0.5 mg (E-Coli)

Recombinant Thermoanaerobacter tengcongensis Putative membrane protein insertion efficiency factor (TTE2800)

View Details

MBS1466070-05 0.05 mg (Baculovirus)

Recombinant Thermoanaerobacter tengcongensis Putative membrane protein insertion efficiency factor (TTE2800)

View Details

MBS1466070-06 0.2 mg (Yeast)

Recombinant Thermoanaerobacter tengcongensis Putative membrane protein insertion efficiency factor (TTE2800)

View Details